Skip to main contentAI and Advanced
/
EXPLEOSOL · NSEMarket ticker unavailable · configure an authorised index feed
EX
NSE · Equity shares · Software & Programming4.00 · 0.46%
Expleo Solutions EXPLEOSOL
NSE:INR 872
BSE:INR 800.35
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for EXPLEOSOL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 868
Day rangeINR 842 — INR 890
52-week rangeINR 640 — INR 1,175.1
Volume44,424
Market cap1,254.14
P/E8.1
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,107.96
Net Income (INR Cr)123.98
Rev Growth (5 Year %)29.78
EPS Growth (5 Year %)10.18
P/E Ratio8.1
Book Value499.89
EPS87.13
Price/BV1.74Computed
Research path: Interpret Expleo Solutions's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
EXPLEOSOLExpleo Solutions1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 928.83 | 831.08 | 764.76 |
| Cash Equivalents | 375.75 | 64.41 | 40.14 |
| Other Liabilities Total | 19.37 | 28.63 | 29 |
| Common Stock Total | 15.52 | 15.52 | 15.52 |
| Other Current Assets Total | 30.69 | 3.2 | 6.32 |
| Total Assets | 928.83 | 831.08 | 764.76 |
| Current Portof LT Debt/Capital Leases | 2.79 | 7.65 | 5.07 |
| Total Equity | 776.31 | 635.84 | 611.15 |
| Long Term Investments | 4.2 | Not available | Not available |
| Retained Earnings(Accumulated Deficit) | 760.79 | 619.66 | 594.96 |
| Total Common Shares Outstanding | 1.55 | 1.55 | 1.55 |
| Tangible Book Valueper Share Common Eq | 499.89 | 402.11 | 377.62 |
| Total Liabilities | 152.52 | 195.23 | 153.6 |
| Total Debt | 7.85 | 29.8 | 26.06 |
| Short Term Investments | 75.18 | 11.83 | 19.91 |
| Cashand Short Term Investments | 450.93 | 229.31 | 196.05 |
| Total Receivables Net | 229.56 | 312.02 | 381.36 |
| Accounts Receivable-Trade Net | 229.56 | 284.32 | 311.82 |
| Property/Plant/Equipment Total-Net | 72.18 | 100.79 | 110.87 |
| Total Current Liabilities | 128.08 | 144.46 | 103.63 |
| Accounts Payable | 57.14 | 61.08 | 27.68 |
| Other Currentliabilities Total | 68.15 | 46.78 | 35.16 |
| Total Long Term Debt | 5.06 | 22.14 | 20.98 |
| Intangibles Net | 0.49 | 11.78 | 23.2 |
| Other Long Term Assets Total | 19.69 | 20.25 | 11.05 |
| Note Receivable-Long Term | 121.08 | 135.09 | 20.04 |
| Total Current Assets | 711.18 | 563.16 | 597.7 |
| Capital Lease Obligations | 5.06 | 22.14 | 20.98 |
| Accumulated Depreciation Total | Not available | -102.4 | -60.64 |
| Accrued Expenses | Not available | 28.95 | 35.71 |
| Prepaid Expenses | Not available | 10.41 | 9.37 |
| Additional Paid-In Capital | Not available | 0.67 | 0.67 |
| Cash | Not available | 153.08 | 135.99 |
| Property/Plant/Equipment Total-Gross | Not available | 203.19 | 171.51 |
| Goodwill Net | Not available | 0 | 1.9 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
| Total Inventory | Not available | 8.22 | 4.6 |
| Long Term Debt | Not available | Not available | 0 |
| Deferred Income Tax | Not available | Not available | 0 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio2.94
Price to Sale Ratio1.13
Growth
Debt 5Yr CAGR %3.73
Margins
Operating Margin 12m11.12
Operating Margin 5y Avg13.1
Net Profit Margin 12m11.19
Net Profit Margin 5y10.71
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.22
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Tata Consultancy Services | INR 2,223.3 | 8.04 L | 15.67 | — |
| Infosys | INR 1,057.3 | 4.29 L | 14.79 | — |
| HCL Technologies | INR 1,238.35 | 3.36 L | 18.81 | — |
| Tech Mahindra | INR 1,565.35 | 1.53 L | 27.9 | — |
| Billionbrains Garage Ventures | INR 204.95 | 1.29 L | 61.26 | — |
Shareholding
Ownership
- Promoter
- 71.05%
- FII
- 0.13%
- MF
- 0.89%
- Other
- 28.82%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Intersect Group and Expleo Launch Strategic Partnership to Empower Palestinian Talents and Enhance Innovation - وكالة صدى نيوزMarket news · 14 Jul 2026, 9:14 pm
Intersect Group and Expleo Launch Strategic Partnership to Empower Palestinian Talents and Enhance Innovation وكالة صدى نيوز
Expleo Solutions Sets Virtual AGM, Skips Dividend to Fund Growth - The Globe and MailMarket news · 11 Jul 2026, 12:44 am
Expleo Solutions Sets Virtual AGM, Skips Dividend to Fund Growth The Globe and Mail
Expleo Solutions Skips Dividend to Prioritize Growth Ahead of August AGM - TipRanksMarket news · 10 Jul 2026, 12:38 am
Expleo Solutions Skips Dividend to Prioritize Growth Ahead of August AGM TipRanks
Price to book forward of Expleo Solutions Limited – BSE:EXPLEOSOL - TradingViewMarket news · 8 Jul 2026, 6:27 pm
Price to book forward of Expleo Solutions Limited – BSE:EXPLEOSOL TradingView
Gujarat Kidney Ltd Shareholders Approve IPO Fund Use Variation - WhalesbookMarket news · 6 Jul 2026, 2:17 pm
Gujarat Kidney Ltd Shareholders Approve IPO Fund Use Variation Whalesbook
Raconteur Global Resources Ltd: Anaaya Management Takes 13.45% Stake via Preferential Allotment - WhalesbookMarket news · 4 Jul 2026, 1:06 pm
Raconteur Global Resources Ltd: Anaaya Management Takes 13.45% Stake via Preferential Allotment Whalesbook
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsFinal Dividend
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results
Rusaka Markets Community
Discussion and sentiment for Expleo Solutions
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Expleo Solutions Limited is an India-based company, which is engaged in providing software services which involve primarily delivering software validation and verification services to the banking, financial services and insurance industries worldwide. The Company’s range of services includes management and solutions, transformation consultancy, digital transformation, product and process engineering, quality and testing and customer support and maintenance. It operates through wholly owned subsidiaries in the United States of America, United Kingdom, United Arab Emirates (UAE), and Singapore and branches in the Philippines and Belgium. The Company supports, manufacturers, and operators in the automotive, aerospace, railway, defense, energy, banking, and insurance industries. The Company’s subsidiaries include Expleo Solutions Pte. Ltd., Expleo Solutions UK Ltd., Expleo Solutions Inc., Expleo Solutions FZE, and Expleo Solutions LLC.
Company facts
- Industry
- Software & Programming
- Sector
- Software & Programming
- NSE Code
- EXPLEOSOL
- BSE Code
- 533121
Questions
Stock FAQ
What is the symbol and ISIN of Expleo Solutions?
Expleo Solutions has the symbol EXPLEOSOL and ISIN - INE201K01015.
What is the current price of Expleo Solutions?
Expleo Solutions is currently trading at INR 872.00.
What are the year high and year low of Expleo Solutions?
Expleo Solutions has a year high of INR 1,175.10 and a year low of INR 640.00.
What is the market capitalization of Expleo Solutions?
Expleo Solutions has a market capitalization of INR 1,254.14 crore.
What is the P/E ratio of Expleo Solutions?
Expleo Solutions has a P/E ratio of 8.10.
What is the dividend yield of Expleo Solutions?
Expleo Solutions has a dividend yield of 0.00%.
How is the financial performance of Expleo Solutions based on revenue, net income, and EPS?
Expleo Solutions has revenue of INR 1,107.96 crore, net income of INR 123.98 crore, and EPS of INR 86.30.
What is the book value of Expleo Solutions?
Expleo Solutions has a book value of INR 499.89.
What is the debt-to-equity ratio of Expleo Solutions?
Expleo Solutions has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Expleo Solutions?
Expleo Solutions has a price-to-book ratio of 1.74 and a price-to-sales ratio of 1.13.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.